🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

According to TikTok, the platform has taken down violative content and prohibited associated keywords and search suggestions. The organization stated it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at residence.

After moments of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.